Abstract：
:Evaluation of: Woynarowski JM, Krugliak M, Ginsburg H: Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs. Mol. Biochem. Parasitol. 154(1), 70-81 (2007) [1] . The sequencing of the malaria genome sought to expose the parasite's ability to cause disease and identify new targets for antimalarial drugs and vaccines. In this study, the authors discovered how malaria genomic DNA, which is unusually rich in adenine and thymine nucleotides, is intrinsically a target for a selective class of compounds. AT-specific DNA-binding agents have previously been shown to have potent antimalarial activity in vitro. The authors used high-resolution bioinformatic tools to explore the genomic basis for this drug susceptibility, first at the level of individual DNA-binding sites, then expanding to the entire genomic context of each malaria chromosome. Their findings revealed a nonrandom distribution and organization of drug-binding sites that can be further exploited to target these AT sequences. Based on these findings, comparative bioinformatics analyses with other parasite genomes may lead to the identification of new target organisms for these AT-specific drugs and have wide implications for the treatment of human and animal parasitic diseases.
journal_name
Pharmacogenomicsjournal_title
Pharmacogenomicsauthors
Yanow SK,Purcell LA,Lee M,Spithill TWdoi
10.2217/14622416.8.9.1267subject
Has Abstractpub_date
2007-09-01 00:00:00pages
1267-72issue
9eissn
1462-2416issn
1744-8042journal_volume
8pub_type
评论,杂志文章相关文献
PHARMACOGENOMICS文献大全abstract：:Aim: The influence of variants in pharmacokinetics-related genes on long-term exposure to tacrolimus (TAC)-based therapy and clinical outcomes was investigated. Patients & methods: Brazilian kidney recipients were treated with TAC combined with everolimus (n = 178) or mycophenolate sodium (n = 97). The variants in CYP...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs-2019-0120
更新日期：2020-01-01 00:00:00
abstract：:The current paradigm of human genetics research is to analyze variation of a single data type (i.e., DNA sequence or RNA levels) to detect genes and pathways that underlie complex traits such as disease state or drug response. While these studies have detected thousands of variations that associate with hundreds of co...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.11.145
更新日期：2012-01-01 00:00:00
abstract：:While different markers for cancer diagnosis have been known for at least a decade, the systematic search for biomarkers emerged only several years ago. In this article, I will concentrate on DNA methylation as a dynamic and robust platform for the development of cancer-specific biomarkers. Simultaneous analysis of a ...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.1517/14622416.5.6.699
更新日期：2004-09-01 00:00:00
abstract：BACKGROUND & METHODS:Economic evaluation in genomic medicine is an emerging discipline to assess the cost-effectiveness of genome-guided treatment. Here, we developed a pharmaco-economic model to assess whether pharmacogenomic (PGx)-guided warfarin treatment of elderly ischemic stroke patients with atrial fibrillation ...
journal_title：Pharmacogenomics
pub_type： 杂志文章,随机对照试验
doi：10.2217/pgs.14.167
更新日期：2015-01-01 00:00:00
abstract：AIM:Gemcitabine is the first chemotherapeutic agent to show clinical benefits in pancreatic cancer patients. While interindividual variability in chemoresponse is observed, genetic factors that affect drug metabolism have not been clearly defined. The purpose of this study is to evaluate the relationships between genet...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.12.82
更新日期：2012-07-01 00:00:00
abstract：:Human cytochrome P450 (CYP)3A is a major P450 enzyme found in the liver and gastrointestinal tract. It plays an important role in the metabolism of a wide variety of drugs, some endogenous steroids and harmful environmental contaminants. It has been shown that CYP3A alleles encoding enzymes with little or no activity ...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/14622416.6.7.731
更新日期：2005-10-01 00:00:00
abstract：:Biobanking became a necessity for translating genetic discoveries into clinical practice. Approaches to personalized medicine require a new model system for functional and pharmacogenomic studies of a variety of accumulating genetic variations, as well as new research environments such as biobankomics. Human lymphobla...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.11.24
更新日期：2011-06-01 00:00:00
abstract：INTRODUCTION:Methotrexate (MTX), widely used in the treatment of rheumatoid arthritis (RA), inhibits dihydrofolate reductase and folate-dependent enzymes. Methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism and has been shown to be polymorphic, affecting the enzyme activity. METHODS:To examine...
journal_title：Pharmacogenomics
pub_type： 临床试验,杂志文章
doi：10.2217/14622416.8.11.1551
更新日期：2007-11-01 00:00:00
abstract：:Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarray technology covered the latest advances in this technology and applications in life sciences. Highlights of the meetings are reported briefly with emphasis on applications in genomics, drug discovery and molecular diagnostics. Ther...
journal_title：Pharmacogenomics
pub_type：
doi：10.1517/14622416.2.1.73
更新日期：2001-02-01 00:00:00
abstract：:Recent advances in next-generation sequencing techniques have greatly improved our understanding of the genomic alterations in bladder cancer. Cisplatin-based chemotherapy provides a viable treatment option in the neoadjuvant, adjuvant and metastatic setting in a selected group of patients, but chemoresistance is a ma...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/pgs-2017-0055
更新日期：2017-08-01 00:00:00
abstract：:Damage to the heart can result from both traditional chemotherapeutic agents, such as doxorubicin, and newer 'targeted' therapies, such as trastuzumab. This chemotherapeutic cardiotoxicity is potentially life-threatening and necessitates limiting or discontinuing an otherwise-effective cancer treatment. Clinical strat...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/pgs.12.205
更新日期：2013-01-01 00:00:00
abstract：AIM:Our objective was to describe the association between voriconazole concentrations and CYP2C19 diplotypes in pediatric cancer patients, including children homozygous for the CYP2C19*17 gain-of-function allele. MATERIALS & METHODS:A linear mixed effect model compared voriconazole dose-corrected trough concentrations...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.14.53
更新日期：2014-06-01 00:00:00
abstract：AIM:The present study introduces a simple method for CYP2D6 genotyping that not only determines the heterozygous or homozygous deletions and duplications, but also distinguishes tandem hybrids. MATERIALS & METHODS:Using two commercially available methods, 49 Korean male subjects were genotyped for CYP2D6. The Affymetr...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.12.58
更新日期：2012-06-01 00:00:00
abstract：:Cancer patients frequently suffer from disease- and treatment-related pain, nausea and depression, which severely reduces patients' quality of life. It is critical that clinicians are aware of drug-gene interactions and recognize the utility of applying pharmacogenetic information to personalize and improve supportive...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/pgs.15.178
更新日期：2016-03-01 00:00:00
abstract：:We report the case of a patient bearing a T315I-mutant chronic myeloid leukemia resistant to nilotinib, successfully treated with omacetaxine and then with dasatinib. After 9 months of nilotinib, the patient achieved a major molecular response but relapsed 3 months later due to the T315I mutation. Because third-genera...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.15.25
更新日期：2015-01-01 00:00:00
abstract：:The most prescribed medication for controlling bronchoconstriction associated with asthma and chronic obstructive pulmonary disease are beta-agonists. The gene ADRbeta2 encodes the beta-2-adrenergic receptor and contains several common genetic variations that affect gene expression and receptor function in vitro. The ...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/14622416.9.3.349
更新日期：2008-03-01 00:00:00
abstract：:The ultrarapid CYP2D6 metabolizer (UM) phenotype is caused by CYP2D6 gene duplications in some, but not all, UM individuals. CYP2D6 and the adjacent pseudogene CYP2D7 are highly homologous; however, CYP2D7 harbors a premature stop codon, which is absent in carriers of the rare CYP2D7 variant rs530303678. We addressed ...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs-2018-0065
更新日期：2018-08-01 00:00:00
abstract：:ALK was first reported in 1994 as a translocation in anaplastic large cell lymphoma and then described with different abnormalities in a number of tumors. Recently, a shortly accumulated biomedical research clarified the numerous biological processes underlying its ability to support cancer development, growth and pro...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs-2016-0166
更新日期：2017-02-01 00:00:00
abstract：:The response to stress triggers transcriptional activation of genes involved in cell survival and/or cell death. Thus, the monitoring of gene expression levels in large gene sets or whole genomes in response to various agents (toxicogenomics) has been proposed as a tool for investigating mechanisms of toxicity. Althou...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.1517/14622416.6.4.419
更新日期：2005-06-01 00:00:00
abstract：:For the last 40 years, 5-fluorouracil (5-FU) has remained the treatment of choice in both the adjuvant and advanced treatment of colorectal cancer (CRC). However, 5-FU monotherapy produces response rates of only 10-20% in the advanced setting. 5-FU has been combined with newer agents, such as oxaliplatin and irinoteca...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/14622416.6.6.603
更新日期：2005-09-01 00:00:00
abstract：:The recent introduction of new microarray expression technologies and the further development of established platforms ensure that the researcher is presented with a range of options for performing an experiment. Whilst this has opened up the possibilities for future applications, such as exon-specific arrays, increas...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/14622416.7.1.123
更新日期：2006-01-01 00:00:00
abstract：:Migraine is considered one of the most disabling neurological disorder with a high socioeconomic burden. Pharmacological management includes many classes of drugs which in the most cases, are administrated in polytherapy. The therapeutic scheme of migraineurs is often affected by comorbidities which need concomitant m...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs-2019-0069
更新日期：2019-11-01 00:00:00
abstract：:The pharmacokinetic and pharmacodynamic disciplines address pharmacological traits, including efficacy and adverse events. Pharmacogenomics studies have identified pervasive genetic effects on treatment outcomes, resulting in the development of genetic biomarkers for optimization of drug therapy. Pharmacogenomics-base...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/pgs.14.144
更新日期：2014-12-01 00:00:00
abstract：AIM:We examined whether HLA-DRB1*1501 and four VDR SNPs influence the macrophage response to infection with Mycobacterium tuberculosis (Mtb) via innate immune versus drug treatment or drug delivery mechanisms. MATERIALS & METHODS:Monocyte-derived macrophages from 24 healthy donors were infected with Mtb in vitro. Surv...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.13.12
更新日期：2013-04-01 00:00:00
abstract：:Chronic obstructive pulmonary disease (COPD) is influenced by genetic and environmental factors. A large number of candidate gene-association studies and genome-wide linkage scans have been conducted to elucidate the genetic architecture underlying this disease. The compilation of these studies clearly revealed the co...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.2217/pgs.09.10
更新日期：2009-04-01 00:00:00
abstract：AIMS:The identification of predictive markers of response to chemoradiotherapy treatment remains a promising approach for patient management in order to obtain the best response with minor side effects. Initially, we investigated whether the analysis of several markers previously studied and others not yet evaluated co...
journal_title：Pharmacogenomics
pub_type： 临床试验,杂志文章
doi：10.2217/pgs.10.51
更新日期：2010-06-01 00:00:00
abstract：:A DNA microarray system is usually comprised of DNA probes formatted on a microscale on a glass surface (chip), plus the instruments needed to handle samples (automated robotics), to read the reporter molecules (scanners) and analyse the data (bioinformatic tools). Biochips are formed by in situ (on chip) synthesis of...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.1517/14622416.1.3.289
更新日期：2000-08-01 00:00:00
abstract：:Quantitative trait analysis (QTA) can be used to test whether the expression of a particular gene significantly correlates with some ordinal variable. To limit the number of false discoveries in the gene list, a multivariate permutation test can also be performed. The purpose of this study is to identify peripheral bl...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/14622416.7.3.395
更新日期：2006-04-01 00:00:00
abstract：:Incidental findings have long posed challenges for healthcare providers, but the scope and scale of these challenges have increased with the introduction of new technologies. This article assesses the impact of incidental findings on the introduction of prospective pharmacogenomic testing into clinical use. Focusing o...
journal_title：Pharmacogenomics
pub_type： 杂志文章
doi：10.2217/pgs.13.119
更新日期：2013-08-01 00:00:00
abstract：:The human oral cavity represents a complex ecology of approximately 500 microbial species existing as commensals, and interacting with human/host factors. Perturbation of this ecosystem can lead to diseases of the oral cavity. The oral cavity also acts as a mirror of complex systemic diseases. Unique challenges and op...
journal_title：Pharmacogenomics
pub_type： 杂志文章,评审
doi：10.1517/phgs.4.2.163.22626
更新日期：2003-03-01 00:00:00
